Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3006695	-toxonho	— (—)	578	1166	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

L04AA Selective immunosuppressants

216

27.90

319.58

3.3

1.1

—

Transplanted organ and tissue status

234

107.78

307.65

3.4

1.0

—

L04AD Calcineurin inhibitors

220

60.78

307.65

3.4

1.1

—

ILD medications: immunosuppressive drugs

308

136

21.20

307.65

2.8

1.1

—

ILD, hospital admission 2, with pulmonary infections

133

98.04

256.11

3.0

1.1

—

Other respiratory diseases principally affecting the interstitium

161

30.41

245.01

3.0

1.8

—

Other interstitial pulmonary diseases

152

35.34

241.84

3.0

1.6

—

ILD, hospital admissions

152

34.58

240.31

3.0

1.6

—

Interstitial lung disease endpoints

152

34.56

240.30

3.0

1.6

—

Interstitial lung disease

152

34.56

240.30

3.0

1.6

—

ILD medications: prednisolone, methylprednisolone, prednisone

332

155

12.03

231.80

2.5

1.1

—

ILD, hospital admissions 1, main diag only

141

38.03

228.79

3.1

1.7

—

ILD, hospital admissions 3, with pneumonia sepsis

114

90.56

217.35

3.0

1.3

—

Oral corticosteroids

332

203

9.74

214.45

2.6

1.2

—

ILD medications

315

156

10.99

205.64

2.3

1.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

149

72.19

202.95

3.1

1.3

—

First line medication for Crohn's disease

298

135

11.97

202.85

2.3

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

303

235

8.69

195.46

2.5

1.6

—

Influenza and pneumonia

313

236

8.46

192.28

2.4

1.6

—

Inflammatory bowel disease treatment related agents

326

206

8.88

191.83

2.5

1.2

—

Pneumonia, organism unspecified

277

215

9.07

188.52

2.5

1.6

—

All pneumoniae

301

242

8.34

188.24

2.5

1.6

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

278

166

10.18

186.75

2.5

1.5

—

278

166

10.18

186.75

2.5

1.5

—

Idiopathic pulmonary fibrosis

100

49.18

172.23

3.6

1.7

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

285

258

7.56

167.47

2.5

1.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

279

231

7.89

165.26

2.8

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

133

15.64

153.88

1.5

2.2

—

Fever of other and unknown origin

194

191

9.08

150.14

1.9

—

Liquid cancers, helper endpoint

159

126

11.09

139.45

1.5

2.3

—

Abnormal findings on diagnostic imaging of lung

161

184

8.43

121.96

2.1

2.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

195

266

6.59

115.91

2.0

2.1

—

Bacterial infection, other or unspecified

169

193

7.63

112.80

1.8

2.2

—

Bacterial pneumonia (organism specified)

149

158

8.60

111.66

2.4

1.7

—

Bacterial infection, other or unspecified

172

206

7.09

106.59

1.8

2.2

—

Implicit viral Sepsis

14.59

104.84

2.4

1.9

—

Viral Sepsis

14.59

104.84

2.4

1.9

—

ILD-related respiratory insufficiency

54.35

99.76

3.7

1.0

—

Early onset COPD, excluding more controls

24.28

98.58

3.3

1.1

—

Other bacterial diseases

231

295

5.28

98.04

2.0

2.1

—

Implicit viral Sepsis

107

105

10.25

95.80

2.4

1.8

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

232

318

5.05

94.98

2.0

—

Bacterial pneumoniae

112

102

9.72

90.69

2.7

1.5

—

Non-Hodgkin lymphoma, all, including Hilmo

18.02

90.55

1.5

2.2

—

Bacterial pneumonia, not elsewhere classified

107

9.56

85.58

2.8

1.5

—

ILD medications: azathioprine

19.87

84.35

2.0

1.1

—

COPD-related respiratory insufficiency

18.34

83.76

3.6

1.4

—

Other diseases of pleura

137

178

6.78

82.97

2.9

1.7

—

Dialysis, with operation codes

15.63

82.02

2.4

2.0

—

Other bacterial diseases

222

302

4.68

80.87

2.0

2.1

—

COPD/asthma related infections

190

166

5.74

75.98

2.1

1.5

—

COPD/asthma/ILD related infections

190

166

5.74

75.98

2.1

1.5

—

Covid-19 confirmed case

110

150

7.37

75.95

2.9

1.7

—

Other respiratory disorders and diseases

11.37

75.87

3.3

1.5

—

Other diseases of the respiratory system

11.37

75.87

3.3

1.5

—

Bacterial Sepsis

131

173

6.50

75.56

2.3

1.9

—

Azathioprine

14.90

73.30

2.0

1.2

—

Implicit bacterial Sepsis

116

148

6.98

72.50

2.4

1.9

—

Protozoal diseases

34.26

71.93

1.8

2.2

—

Other diseases of blood and blood-forming organs, wide

9.51

71.22

1.9

—

Infections, IBD-co-morbidities

18.24

70.72

2.5

1.2

—

Viral infections characterized by skin and mucous membrane lesions

122

203

6.03

69.71

2.2

1.9

—

Provisional assignment of new diseases of uncertain etiology

136

252

5.41

69.28

2.7

1.7

—

Codes for special purposes

136

255

5.34

68.39

2.7

1.7

—

Second line medication for Crohn's disease

151

313

4.84

67.82

2.2

2.1

—

L04AX Other immunosuppressants

147

300

4.92

67.26

2.2

2.0

—

Implicit bacterial Sepsis

119

164

6.29

66.93

2.3

1.9

—

Nephropathy related operations

12.41

65.86

2.4

2.1

—

Non-follicular lymphoma

16.40

65.05

1.4

1.8

—

Fungal Sepsis

29.44

64.32

2.2

—

Viral pneumonia

19.38

64.12

2.6

1.2

—

Implicit fungal Sepsis

21.72

63.09

2.1

1.9

—

Persons encountering health services for specific procedures and health care

212

318

4.00

62.98

2.3

1.9

—

Dental caries

115

7.57

62.54

2.7

2.0

—

Implicit Sepsis

164

272

4.56

62.30

2.4

1.9

—

COPD (mode)

14.24

61.86

3.2

1.1

—

Implicit fungal Sepsis

30.11

61.73

2.2

2.3

—

Any death

150

224

4.81

59.41

1.9

2.3

—

Certain infectious and parasitic diseases

159

151

5.28

59.04

2.1

1.5

—

Caries of dentine

100

7.93

58.85

2.8

2.1

—

Certain disorders involving the immune mechanism

8.76

58.14

1.9

—

Chronic kidney disease

106

7.62

57.88

2.1

1.8

—

Oxycodone

102

150

6.17

57.48

1.8

2.0

—

206

268

3.98

57.13

2.3

1.6

—

Mycoses

126

6.95

56.99

2.6

1.8

—

Viral infections characterized by skin and mucous membrane lesions

177

393

3.86

56.76

2.1

2.0

—

Pulmonary heart disease, diseases of pulmonary circulation

132

6.70

55.76

2.5

1.9

—

Acute bronchitis

100

167

5.89

55.50

3.2

1.6

—

Implicit Sepsis

167

297

4.12

55.46

2.4

1.9

—

General symptoms and signs

188

224

4.21

55.09

2.0

1.9

—

Bronchitis

202

345

3.69

55.08

2.5

1.6

—

Other medical care

108

174

5.60

55.08

2.0

1.7

—

All influenza

9.73

54.43

2.4

1.4

—

Other acute lower respiratory infections

125

251

4.76

54.30

3.0

1.7

—

Inflammatory diseases of the central nervous system

13.69

53.64

1.5

2.1

—

Other viral diseases

138

6.39

53.25

2.4

1.9

—

Condition for Implicit Sepsis (Organ dysfunction codes)

168

301

3.95

52.19

2.4

1.9

—

Diagnoses used for exclusion with ILD

105

7.18

50.68

2.1

2.0

—

Renal failure

110

194

5.03

49.67

2.2

2.1

—

Asthma

111

6.34

49.64

2.7

1.2

—

Early onset COPD

7.57

49.54

3.3

1.8

—

Asthma, excluding more controls

109

6.33

48.56

2.8

1.2

—

Anaemias

12.11

47.53

2.1

1.3

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

7.53

47.37

3.3

1.6

—

Asthma (only as main-diagnosis), excluding more controls

100

6.36

47.02

2.8

1.2

—

Respiratory insufficiency

76.68

46.97

3.6

1.1

—

Asthma (only as main-diagnosis)

100

6.30

46.93

2.8

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

166

310

3.70

46.92

2.5

1.9

—

Zoster [herpes zoster]

9.10

46.83

2.2

1.7

—

Septicaemia

157

5.50

46.76

1.9

2.1

—

Emphysema

17.47

46.30

3.1

1.5

—

Explicit Sepsis

175

5.19

46.30

1.9

1.8

—

Other pulmonary diagnosis

110

6.00

45.90

2.2

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

147

282

3.87

45.34

2.5

1.8

—

Excluding asthma or asthma-COPD overlap

109

5.94

45.14

2.2

1.2

—

Other viral diseases

182

5.09

44.33

2.4

2.1

—

Other septicaemia

134

5.83

44.25

1.9

2.1

—

Pneumonia due to other infectious organisms, not elsewhere classified

99.60

44.07

1.9

1.4

—

COPD differential diagnosis

108

5.83

43.97

2.2

1.3

—

ILD differential diagnosis

108

5.83

43.97

2.2

1.3

—

Agranulocytosis

10.53

43.74

1.9

2.2

—

Asthma-related pneumonia

171

5.15

42.66

3.1

1.7

—

Asthma, hospital admissions 3, pneumonia

171

5.15

42.65

3.1

1.7

—

Asthma-related pneumonia or sepsis

171

5.15

42.65

3.1

1.7

—

Any gastric operation

108

5.59

42.45

2.1

1.3

—

GASTRO-related operations

108

5.59

42.45

2.1

1.3

—

Heart failure, not strict

151

284

3.62

41.25

2.5

1.9

—

Diseases of oesophagus, stomach and duodenum

188

351

3.21

41.17

2.7

1.7

—

Zoster [herpes zoster]

216

4.52

40.98

2.2

1.8

—

Acute upper respiratory infections

177

331

3.30

40.88

2.2

1.8

—

COPD, hospital admission 2, with asthma infections

110

5.95

40.50

3.3

1.8

—

Failure and rejection of transplanted organs and tissues

78.08

38.60

3.4

2.2

—

Acute sinusitis

104

232

4.16

38.00

2.5

1.7

—

Acute renal failure

7.50

37.27

2.4

2.1

—

Asthma, unspecified (mode), excluding more controls

6.61

37.20

2.7

1.2

—

Care involving use of rehabilitation procedures

114

276

3.81

36.87

2.3

1.9

—

Malignant neoplasm

147

248

3.51

36.74

1.7

2.4

—

Asthma, unspecified (mode)

6.48

36.68

2.7

1.3

—

Dyspnoea

158

368

3.18

36.56

2.4

1.9

—

Tramadol

137

232

3.63

36.42

2.3

1.9

—

Autoimmune diseases excluding thyroid diseases, strict definition

179

315

3.12

36.41

1.8

2.2

—

Renal tubulo-interstitial diseases

155

362

3.19

36.24

2.2

1.9

—

Malignant neoplasm, wide definition for exclusion

150

257

3.43

36.10

2.0

2.4

—

Percutaneous Coronary Intervention

141

246

3.52

35.81

3.2

1.4

—

Autoimmune diseases excluding thyroid diseases

181

324

3.05

35.59

1.8

2.2

—

COPD

176

4.38

35.23

3.0

1.7

—

Coronary revascularization (ANGIO or CABG)

140

246

3.49

35.14

3.2

1.4

—

Hard cardiovascular diseases

145

253

3.42

35.06

2.9

1.4

—

Abnormalities of breathing

145

250

3.37

34.03

2.3

1.8

—

All chronic kidney diseases

108

232

3.82

33.86

2.1

2.0

—

Pneumocystosis

40.67

33.80

1.8

1.4

—

Pain, not elsewhere classified

6.27

32.85

3.3

1.9

—

Emergency coronary revascularization (for ACS)

144

268

3.27

32.82

3.2

1.4

—

Asthma (mode)

5.07

32.70

2.4

1.3

—

COPD, hospital admissions 1, only main diagnosis

123

4.96

31.33

3.3

1.8

—

All kidney diseases

163

388

2.87

31.25

2.2

2.0

—

Any reimbursement code in KELA

5.67

31.16

2.2

1.0

—

Ischemic heart diseases

138

259

3.21

30.39

3.1

1.4

—

Pulmonary embolism

120

5.18

30.36

2.1

1.9

—

Reimbursement for rheumatic diseases

104

302

3.44

29.66

1.8

2.0

—

Enlarged lymph nodes

8.16

29.45

1.2

2.0

—

Major coronary heart disease event

138

266

3.14

29.44

3.2

1.4

—

Viral warts

9.78

29.43

2.4

1.8

—

Other chronic obstructive pulmonary disease

168

4.13

29.42

3.1

1.7

—

Secondary uncertain malignant neoplasm

10.05

29.14

1.2

2.1

—

Pulmonary heart disease

126

4.94

28.74

2.1

2.0

—

L01XE Protein kinase inhibitors

11.26

28.48

2.2

1.8

—

Neoplasms

116

173

3.56

28.43

2.2

2.0

—

Other metabolic disorders

7.36

28.38

2.9

1.6

—

Autoimmune diseases related-to ILD

119

324

3.15

28.37

1.7

—

Drug-induced neutropenia

10.44

28.02

1.9

1.7

—

Examination and observation for other reasons

101

155

3.78

27.76

2.5

1.5

—

Lung diseases due to external agents

8.08

27.71

2.5

1.9

—

Continuous positive airway pressure

6.62

27.59

2.8

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

5.71

27.18

1.6

1.9

—

Disorders of lens

121

236

3.21

27.07

2.4

2.1

—

All influenza (not pneumonia)

9.45

27.04

2.6

1.3

—

Any event in cancer register

142

286

2.93

26.90

1.7

2.4

—

Viral warts

5.88

26.90

2.2

1.7

—

Cytomegaloviral disease

28.81

26.86

2.6

2.3

—

Non-Hodgkin lymphoma, all

41.97

26.82

1.2

2.8

—

Asthma-related infections

105

322

3.20

26.66

2.8

1.8

—

Asthma, hospital admission 2, infections

105

322

3.20

26.66

2.8

1.8

—

COPD related to multimorbidity

157

4.10

26.59

3.1

1.9

—

Other cataract

160

3.94

26.56

2.1

2.2

—

Cytomegalovirus infection, IBD co-morbidity

26.79

26.36

2.6

2.2

—

Certain infectious and parasitic diseases

115

4.06

26.36

2.1

1.6

—

COPD, hospital admissions

190

3.75

26.05

3.1

1.9

—

Intestinal infectious diseases

148

421

2.67

25.62

2.1

2.0

—

Diffuse large B-cell lymphoma, including Hilmo

33.61

25.60

1.6

2.4

—

Diffuse large B-cell lymphoma

33.61

25.60

1.6

2.4

—

Diffuse large B-cell lymphoma, helper endpoint

33.61

25.60

1.6

2.4

—

COPD, early/later onset

192

3.70

25.54

3.1

1.9

—

Aplastic and other anaemias

214

3.62

25.26

2.2

1.9

—

DVT of lower extremities and pulmonary embolism

214

3.69

25.09

2.2

1.8

—

Osteopathies and chondropathies

283

3.23

25.02

2.0

1.9

—

Diarrhoea and gastroenteritis of presumed infectious origin

117

361

2.92

24.99

2.0

—

Seborrhoeic keratosis

5.63

24.69

2.5

2.0

—

Unspecified acute lower respiratory infection

6.82

24.58

3.2

1.2

—

Chronic lower respiratory diseases

179

383

2.49

24.46

2.7

1.7

—

Other/unspecified cytomegaloviral diseases

30.40

24.27

2.7

1.4

—

Herpesviral [herpes simplex] infections

7.60

24.18

1.9

1.7

—

Other and unspecified anaemias

197

3.69

23.87

2.2

1.8

—

Other anaemias

198

3.66

23.60

2.2

1.8

—

Other reaction to severe stress, and adjustment disorders

190

3.75

23.15

2.4

1.9

—

Secondary right heart disease

22.43

23.05

3.7

1.7

—

Other pulmonary heart/vessel disease

20.36

23.03

3.6

1.6

—

Other disorders of skin and subcutaneous tissue

111

344

2.87

22.93

2.3

1.9

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

6.89

22.88

1.2

2.2

—

Cough

171

3.83

22.84

2.3

1.8

—

235

3.38

22.37

2.8

1.8

—

Diseases of the respiratory system

4.35

22.21

2.0

1.3

—

Venous thromboembolism

284

3.10

21.95

2.1

2.0

—

Myeloid leukaemia

29.81

21.95

1.4

1.7

—

Heart failure and antihypertensive medication

4.94

21.88

2.4

1.2

—

Encephalitis

25.61

21.82

1.5

1.6

—

Candidiasis

6.35

21.78

2.6

1.5

—

Cardiovascular diseases (excluding rheumatic etc)

156

3.36

21.34

2.3

1.4

—

5.87

21.31

3.5

1.8

—

Immunodeficiencies

19.13

21.29

1.6

—

Dermatitis

101

353

2.86

21.25

2.2

1.9

—

Osteoporosis

101

4.64

21.17

2.1

1.6

—

Other encephalitis

28.70

21.01

1.5

1.7

—

Other chronic obstructive pulmonary disease, including avohilmo

240

3.10

20.93

3.1

1.9

—

Other and unspecified dermatitis

294

3.03

20.87

2.0

1.8

—

Metabolic disorders

138

329

2.56

20.87

2.6

1.9

—

Other heart diseases

125

3.71

20.10

2.3

1.3

—

Allergic asthma (mode)

6.75

19.77

2.4

1.1

—

Chorioretinal inflammation

25.10

19.59

1.4

2.5

—

Enterocolitis due to Clostridium difficile

7.75

19.53

2.0

1.9

—

Headache

208

3.15

19.42

1.7

1.9

—

Allergic asthma (mode), excluding more controls

6.61

19.37

2.4

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

132

3.98

19.30

1.6

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.50

19.18

3.1

2.1

—

Pleural effusion

6.69

19.10

2.7

1.5

—

Solid cancers, helper endpoint

113

246

2.72

18.94

1.7

2.4

—

Complications of medical and surgical care

111

396

2.58

18.94

2.1

2.0

—

Gastro-oesophageal reflux disease

312

2.74

18.75

2.5

1.7

—

Opioids

129

262

2.56

18.60

2.3

1.9

—

Malaise and fatigue

153

3.48

18.26

2.0

1.9

—

Systemic connective tissue disorders

165

3.58

18.13

1.7

1.8

—

Autoimmune diseases

150

326

2.34

17.94

1.9

2.2

—

Other bacterial intestinal infections

5.09

17.84

2.0

1.9

—

Drug-induced cataract

23.35

17.82

2.5

1.7

—

Intestinal infectious diseases

157

399

2.25

17.77

2.0

—

Care involving dialysis

13.75

17.73

1.6

1.9

—

Kidney transplant status

13.22

17.44

2.2

2.8

—

Purpura and other haemorrhagic conditions

5.53

17.40

1.3

1.9

—

Other viral diseases, not elsewhere classified

4.65

17.39

2.9

2.0

—

Immunodeficiency with predominantly antibody defects

24.53

17.37

1.3

1.7

—

Pain in throat and chest

108

246

2.64

17.31

2.1

1.8

—

Hypo-osmolality and hyponatraemia

5.49

17.26

1.3

1.7

—

Presence of other functional implants

137

3.40

17.13

1.7

1.1

—

Sarcoidosis

5.26

16.99

2.1

—

Bacterial intestinal infections, IBD co-morbidities

4.82

16.80

2.0

1.9

—

Secondary and unspecified malignant neoplasm of lymph nodes

14.10

16.77

1.2

2.1

—

Mycoses

122

454

2.34

16.75

2.3

1.9

—

Senile cataract

208

2.77

16.62

2.6

2.1

—

Other and unspecified polyneuropathies, also in other diseases

4.65

16.53

2.2

1.9

—

Dermatitis and eczema

150

423

2.20

16.51

2.2

1.9

—

Polyneuropathies and other disorders of the peripheral nervous system

4.33

16.34

2.1

2.0

—

Focal epilepsy, strict definition

4.36

16.09

1.7

1.9

—

Epilepsy

159

3.46

16.03

1.7

1.8

—

Convulsions, not elsewhere classified

4.75

16.02

2.0

2.1

—

Cardiovascular diseases

138

3.08

15.99

2.1

1.4

—

Lymphoid leukaemia

12.32

15.84

1.4

2.0

—

Disorders of eyelid, lacrimal system and orbit

118

384

2.34

15.71

2.0

2.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

135

399

2.23

15.66

2.0

—

Asthma/COPD (KELA code 203)

127

382

2.28

15.65

2.8

1.7

—

Other heart diseases, wide

125

329

2.33

15.61

2.2

1.9

—

Focal epilepsy

103

4.09

15.55

1.7

1.9

—

Candidiasis

135

3.64

15.45

2.3

1.7

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

4.38

15.38

1.8

1.9

—

Nausea and vomiting

115

3.84

15.25

1.7

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

16.23

15.25

1.6

1.7

—

Symptoms and signs involving the circulatory and respiratory systems

121

253

2.40

15.23

2.1

1.8

—

Dermatophytosis

5.49

15.22

2.1

1.7

—

Viral pneumonia (unknown virus, not influenza)

13.11

15.16

2.7

2.2

—

Abnormal findings on diagnostic imaging of central nervous system

17.89

15.15

1.2

2.2

—

Other bacterial intestinal infections

4.13

15.05

2.0

1.9

—

Complications of surgical and medical care, not elsewhere classified

134

419

2.19

15.05

2.1

2.0

—

Melanocytic naevi

138

3.56

14.97

2.8

1.7

—

Iridocyclitis

111

3.89

14.88

1.2

2.1

—

Persons encountering health services in other circumstances, wide

150

360

2.15

14.86

2.1

1.9

—

Cerebrovascular diseases (FINNGEN)

3.87

14.85

1.8

1.3

—

Rare circulating lymphoid malignancy, including Hilmo

32.15

14.83

1.5

1.8

—

Haemorrhage from respiratory passages

132

3.49

14.73

2.7

1.7

—

Medical observation and evaluation for suspected diseases and conditions

157

2.80

14.69

2.2

1.5

—

Malignant neoplasm of brain, including Hilmo

25.22

14.68

1.5

2.8

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

143

360

2.16

14.62

2.1

1.9

—

Aspergillosis

38.08

14.60

3.6

1.2

—

General examination and investigation of persons without complaint and reported diagnosis

157

2.80

14.37

2.5

1.5

—

Non-invasive ventilation

4.15

14.30

2.6

1.2

—

Cystic fibrosis with pulmonary manifestations

+∞

14.23

4.5

0.0

—

Viral pneumonia (known virus, not influenza)

20.38

13.81

2.8

2.0

—

Disorders of sclera, cornea, iris and ciliary body

325

2.53

13.79

1.6

2.0

—

Pneumothorax

10.48

13.71

3.4

2.2

—

Hypertension, Pulmonary Arterial

+∞

13.63

4.8

0.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

4.42

13.44

2.4

1.3

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.78

13.43

2.1

1.7

—

Cardiac arrhythmias

170

2.79

13.41

2.4

1.4

—

Asthma (diagnoses ohter than nonallergic)

115

438

2.18

13.36

2.7

1.9

—

Other skin changes

4.36

13.30

2.5

1.9

—

Heart failure,strict

200

2.69

13.30

2.1

2.0

—

Disorders of lacrimal system

206

2.91

13.25

2.0

1.8

—

Oedema, not elsewhere classified

110

3.68

13.16

3.1

1.8

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

347

2.42

13.04

2.2

2.1

—

Cystic fibrosis with intestinal manifestations

+∞

13.01

4.8

0.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

116

3.16

13.00

2.0

1.3

—

Other viral diseases, not elsewhere classified

118

3.55

12.80

2.8

1.8

—

Used for control exclusion in common control thyroid runs

129

306

2.13

12.58

1.9

2.2

—

Malignant neoplasm of eye, brain and central nervous system

24.49

12.47

1.6

3.0

—

Diseases of the skin and subcutaneous tissue

119

273

2.19

12.34

2.5

1.7

—

Diaphragmatic hernia

188

2.93

12.34

2.0

1.8

—

Bleeding

111

365

2.16

12.30

2.4

2.0

—

Viral infections of the central nervous system

10.52

12.23

1.5

2.5

—

Hypertensive diseases (excluding secondary)

122

2.96

12.16

2.5

1.3

—

Respiratory disorders in diseases classified elsewhere

27.47

12.11

2.2

1.3

—

Chronic sinusitis

251

2.63

12.10

2.6

1.8

—

Symptoms and signs involving the skin and subcutaneous tissue

412

2.23

12.03

2.4

1.9

—

Glomerular diseases

3.92

11.97

1.5

2.0

—

Anterior Iridocyclitis

101

3.67

11.90

1.3

1.9

—

Herpesviral [herpes simplex] infections

106

3.59

11.84

1.8

1.7

—

Other necrotizing vasculopathies (FG)

10.56

11.75

1.6

2.0

—

Other necrotizing vasculopathies

9.65

11.72

1.6

1.7

—

Status epilepticus

19.08

11.59

1.2

1.9

—

Chronic lymphocytic leukaemia, helper endpoint

23.18

11.59

1.0

3.0

—

Chronic lymphocytic leukaemia

23.18

11.59

1.0

3.0

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

23.18

11.59

1.0

3.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

157

2.55

11.42

2.4

1.5

—

Glomerular disorders in diseases classified elsewhere

4.83

11.41

1.6

2.1

—

Other disorders of lacrimal gland

170

2.95

11.35

2.0

1.8

—

Bronchiectasis

9.62

11.23

2.0

1.4

—

Atrial fibrillation and flutter

3.45

11.12

2.7

1.3

—

Viral infections of the central nervous system

8.57

11.01

1.5

2.3

—

Osteonecrosis

9.24

10.99

1.9

1.8

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

137

2.83

10.91

2.2

2.4

—

Gastroduodenal ulcer

3.65

10.87

2.0

1.7

—

Codeine

103

258

2.17

10.80

2.4

1.8

—

Factors influencing health status and contact with health services

4.48

10.69

2.5

1.1

—

Malignant neoplasm of brain

21.64

10.69

1.6

3.0

—

Thrombocytopenia, unspecified

7.99

10.58

1.4

2.0

—

Chronic gastritis

110

3.37

10.50

3.1

1.6

—

Heart failure and coronary heart disease

128

2.88

10.44

2.2

1.3

—

Erysipelas

221

2.52

10.42

1.8

2.2

—

Gastrointestinal diseases

124

2.67

10.39

2.2

1.4

—

Extracorporeal dialysis

8.21

10.31

1.6

2.1

—

Bacterial, viral and other infectious agents

5.14

10.30

2.3

—

Heart failure, strict

233

2.33

10.23

2.1

—

Asthma, hospital admissions , main diagnosis only

102

442

2.04

10.20

2.8

1.9

—

Multiple myeloma, including Hilmo

14.66

10.00

1.7

2.3

—

All-cause Heart Failure

227

2.34

9.99

2.1

—

Bacterial, viral and other infectious agents

5.15

9.83

2.3

—

STROKE

183

2.45

9.71

1.8

1.4

—

Paroxysmal tachycardia

3.71

9.68

1.9

1.3

—

Visual disturbances and blindness

287

2.34

9.65

1.6

1.9

—

Benign neoplasms

121

343

1.95

9.64

2.2

1.9

—

Explicit bacterial Sepsis

5.29

9.62

1.7

2.0

—

Erysipelas

258

2.25

9.51

1.7

2.2

—

Myeloproliferative diseases

7.13

9.49

1.3

1.8

—

Other and unspecified immunodeficiencies with predominantly antibody defects

18.00

9.45

1.5

1.9

—

Anxiety disorders, excluding more controls

105

343

1.99

9.33

2.4

2.0

—

Polyarthropathies

305

2.06

9.31

1.6

2.2

—

Dysphagia

109

3.22

9.27

1.6

1.8

—

Statin medication

205

2.22

9.15

2.9

1.2

—

Neurotic, stress-related and somatoform disorders

111

403

1.93

9.15

2.3

2.0

—

Chronic iridocyclitis

8.33

9.06

1.2

2.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

4.58

9.05

1.5

1.7

—

Anxiety disorders

111

403

1.92

9.04

2.3

2.0

—

Abnormalities of heart beat

145

2.84

8.99

2.2

1.5

—

Insulin, combination of fast acting with intermediate-acting or long-acting

340

2.13

8.95

2.5

2.0

—

Diseases of the eye and adnexa

218

2.12

8.94

2.0

1.9

—

Gastric ulcer

4.19

8.90

2.3

1.5

—

Symptoms and signs involving the digestive system and abdomen

118

308

1.92

8.89

2.1

—

Malignant neoplasm of skin

144

2.57

8.79

1.9

2.5

—

Other disorders of conjunctiva

4.01

8.77

1.8

2.0

—

Unspecified kidney failure

7.17

8.71

2.4

2.1

—

Nutritional anaemias

241

2.36

8.69

1.9

—

SLE (Finngen)

14.13

8.69

1.9

1.5

—

Presence of cardiac and vascular implants and grafts

108

2.89

8.67

2.0

1.1

—

Sulfasalazine

3.55

8.65

1.3

1.2

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

7.60

8.61

2.0

1.9

—

Benign neoplasm of other and ill-defined parts of digestive system

3.72

8.59

2.5

1.7

—

Preparatory care for dialysis

9.03

8.53

1.2

2.4

—

Coronary atherosclerosis

204

2.23

8.53

2.5

1.4

—

Non-ischemic cardiomyopathy

111

2.91

8.50

2.0

1.6

—

Infection due to other mycobacteria

20.36

8.50

2.7

1.2

—

Other gastritis (incl. Duodenitis)

3.34

8.46

2.6

1.5

—

Procreative management

144

2.67

8.45

2.5

2.0

—

Pain in limb

103

358

1.93

8.42

2.3

1.9

—

Neurological diseases

232

2.04

8.34

2.1

—

Acute bronchiolitis

11.31

8.29

2.2

1.8

—

Viral encephalitis, not elsewhere classified/unspecified

14.66

8.22

1.5

1.3

—

Secondary hypertension

10.62

8.21

1.4

1.2

—

Vocal cord dysfunction

4.49

8.17

1.6

1.2

—

Other diseases of intestines

122

381

1.82

8.14

2.1

2.0

—

Abdominal and pelvic pain

115

308

1.88

8.14

2.2

2.1

—

Neurological diseases, wide definition

3.53

8.11

2.2

1.3

—

Acute and subacute iridocyclitis

3.17

8.06

1.3

2.0

—

Retinal detachments and breaks

187

2.52

8.02

1.6

2.1

—

Polycythaemia vera

22.17

8.02

1.5

3.8

—

Iron deficiency anaemia

208

2.42

7.98

2.1

1.9

—

Maternal care for known or suspected fetal abnormality and damage

3.45

7.97

1.4

1.7

—

Functional dyspepsia

120

2.92

7.94

3.2

1.5

—

Non-allergic asthma (mode)

6.20

7.92

3.3

1.1

—

Covid-19 suspected case

3.20

7.91

2.3

1.5

—

Cardiodefibrillation

194

2.47

7.89

2.4

2.1

—

Other diseases of upper respiratory tract

126

366

1.80

7.87

2.0

1.9

—

Undetermined asthma

7.74

7.85

2.1

1.1

—

Undetermined asthma, excluding more controls

7.74

7.85

2.1

1.1

—

Non-rheumatic valve diseases

180

2.33

7.81

1.7

2.0

—

Systemic lupus erythematosus

10.86

7.80

1.9

1.4

—

Insulin medication

329

2.02

7.79

2.5

2.0

—

Disorders of choroid and retina

363

1.90

7.76

1.6

2.2

—

Non-allergic asthma (mode), excluding more controls

6.01

7.75

3.4

1.1

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

3.30

7.74

1.0

2.3

—

Visual disturbances

271

2.22

7.73

1.6

1.9

—

Ulcer of lower limb, not elsewhere classified

4.18

7.72

1.2

2.1

—

Hernia of abdominal wall, postoperative

6.34

7.69

1.8

1.5

—

Valvular heart disease excluding rheumatic fever

182

2.30

7.64

1.7

2.0

—

Disorders of optic nerve and visual pathways

4.52

7.64

2.1

1.7

—

Obesity related asthma

187

2.46

7.53

2.7

1.8

—

Diseases of arteries, arterioles and capillaries

297

1.99

7.40

2.0

2.1

—

Chronic myeloid leukaemia

+∞

7.34

1.0

0.0

—

Asthma and opportunity respiratory infection

8.39

7.32

2.9

1.9

—

Meningitis

8.38

7.31

1.3

2.9

—

Chronic periodontitis, including avohilmo

111

416

1.79

7.30

2.6

1.9

—

Other disorders involving the immune mechanism, not elsewhere classified

10.94

7.30

2.0

—

Retinal vascular occlusion

5.78

7.20

1.7

1.8

—

Retinal vascular disorders

5.77

7.20

1.7

1.8

—

Periodontitis

111

417

1.78

7.20

2.6

1.9

—

Budesonide

4.48

7.17

2.1

1.2

—

Intracranial and intraspinal abscess and granuloma

20.43

7.16

2.1

1.4

—

Atypical mycobacterium lung infection

20.42

7.16

3.0

1.4

—

Antihypertensive medication - note that there are other indications

164

2.17

7.11

2.6

1.2

—

Persons encountering health services for specific procedures, not carried out

6.56

7.10

3.1

1.7

—

12.14

7.09

2.5

1.6

—

Codeine or tramadol medication

129

412

1.71

7.03

2.4

1.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

128

2.47

6.97

1.9

2.4

—

Other soft tissue disorders, not elsewhere classified

111

367

1.77

6.92

2.4

2.0

—

Wegener granulomatosis

13.99

6.91

2.0

1.5

—

Other meningitis

13.96

6.91

1.3

—

Disorders of oesophagus in diseases classified elsewhere

13.92

6.90

2.8

1.3

—

Tuberculosis

7.54

6.89

1.9

1.6

—

Other symptoms and signs involving the digestive system and abdomen

3.44

6.82

2.1

1.7

—

DVT of lower extremities

3.18

6.82

2.2

2.0

—

Other neurological diseases

355

1.88

6.81

1.6

2.1

—

Multiple myeloma and malignant plasma cell neoplasms

6.72

6.81

1.7

1.9

—

Invasive ventilation

6.70

6.80

1.3

2.1

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

11.01

6.80

2.1

—

Gingival hyperplasia

9.36

6.79

2.5

1.9

—

Tuberculosis, IBD comorbidity

7.17

6.69

1.9

2.0

—

Depression medications

3.63

6.69

2.1

1.3

—

Infections of the skin and subcutaneous tissue

359

1.96

6.68

2.0

2.1

—

Insulin, fast-acting

192

2.35

6.67

2.7

1.9

—

Carcinoma in situ of skin of other and unspecified parts of face

6.43

6.63

3.0

1.5

—

Streptococcal septicaemia

6.42

6.62

1.8

2.3

—

Other and unspecified iron deficiency

151

2.52

6.56

2.2

1.9

—

SLE, strict definition

10.08

6.54

2.0

1.6

—

SLE, ICD10

10.08

6.54

2.0

1.6

—

Haemolytic anaemias

10.08

6.54

2.0

1.5

—

Biological medication for rheuma

2.95

6.52

1.3

2.0

—

Syncope and collapse

143

2.46

6.52

2.0

1.9

—

171

2.36

6.52

2.8

1.6

—

Actinic keratosis

156

2.44

6.51

2.9

1.6

—

Sequelae of external causes of morbidity and mortality

123

2.69

6.48

1.9

2.0

—

Ischaemic heart disease, wide definition

307

1.84

6.46

2.5

2.0

—

Speech therapy

129

2.64

6.45

2.7

1.9

—

Other infectious diseases

5.16

6.31

1.4

2.3

—

Other diseases of intestine

3.45

6.27

2.1

1.7

—

Methotrexate

5.01

6.17

1.2

—

Tuberculosis, wide

6.27

6.15

1.9

—

Carcinoma in situ of skin

5.74

6.13

3.9

1.8

—

Skin changes due to chronic exposure to nonionizing radiation

160

2.37

6.13

2.9

1.6

—

Hypercalcemia

7.70

6.12

1.8

1.6

—

Drug-induced osteoporosis with pathological fracture

12.69

6.10

2.7

1.4

—

Respiratory conditions due to other external agents

12.65

6.09

1.5

1.9

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

310

1.98

6.08

2.3

2.0

—

Melanocytic naevi, other sites/unspecified

4.12

6.08

3.2

2.1

—

Benign neoplasm: Skin of other and unspecified parts of face

4.11

6.08

2.1

1.7

—

Adjustment and management of implanted device

3.76

6.08

2.2

1.7

—

Systemic lupus erythematosus, unspecified

10.08

6.04

2.0

1.6

—

Disorders of calcium metabolism

6.70

6.03

2.0

1.2

—

Other disorders of eyelid

191

2.24

6.02

2.0

1.8

—

Presence of other devices

3.44

5.95

1.8

1.1

—

Mature T/NK-cell lymphomas, hilmo

15.24

5.92

1.4

1.3

—

Asthma and allergy, excluding more controls

5.93

5.92

2.3

1.1

—

Asthma and allergy

5.93

5.92

2.3

1.1

—

Insulin, fast-acting or short human

203

2.22

5.90

2.7

1.9

—

Pneumonia due to Streptococcus pneumoniae

15.06

5.90

1.7

1.3

—

Use of hypnotics and sedatives

118

408

1.66

5.89

2.1

2.0

—

Squamous cell neoplasms and carcinomas of the skin

8.02

5.83

1.7

2.1

—

Abnormal findings on examination of blood, without diagnosis

260

2.01

5.77

2.6

2.2

—

Hernia

102

402

1.70

5.75

2.0

—

Disorders of other endocrine glands

234

2.10

5.75

1.7

1.9

—

Diplopia

3.46

5.72

1.8

1.9

—

Vitreous haemorrhage

3.91

5.71

1.5

2.1

—

Other pleural conditions

5.18

5.69

2.8

1.5

—

Dermatitis due to substances taken internally

6.12

5.69

2.7

2.3

—

Missing teeth due to accident, extraction or parodontitis

341

1.88

5.68

2.5

2.0

—

Nonsuppurative otitis media

103

2.61

5.61

2.0

1.8

—

Drug-induced osteoporosis

13.08

5.60

2.4

1.4

—

Elevated blood glucose level

4.74

5.60

2.6

2.4

—

Cutaneous abscess, furuncle and carbuncle

127

2.52

5.60

1.6

1.9

—

Diseases of spleen

13.01

5.59

1.1

1.6

—

Need for immunization against other single viral diseases

13.00

5.59

2.3

1.3

—

Other dialysis

8.53

5.56

1.2

2.5

—

Other disorders of white blood cells

6.53

5.55

2.4

2.0

—

Viral and other specified intestinal infections

2.75

5.55

2.1

1.9

—

Hypersensitivity pneumonitis due to organic dust

10.15

5.55

4.4

1.7

—

Cerebrovascular diseases

333

1.77

5.54

1.7

2.2

—

Acquired haemolytic anaemia

10.10

5.54

1.5

1.3

—

Demyelinating diseases of the central nervous system

3.82

5.53

1.8

2.0

—

Pneumonitis due to solids and liquids

5.37

5.53

2.2

1.8

—

Symptoms and signs concerning food and fluid intake

5.36

5.52

2.0

—

In situ neoplasms

184

2.23

5.48

2.8

1.7

—

Other inflammation of eyelid

3.34

5.43

1.5

1.9

—

Speech disturbances, not elsewhere classified

4.86

5.42

1.3

1.7

—

Viral and other specified intestinal infections

130

2.45

5.41

1.9

—

Gingivitis and periodontal diseases

106

326

1.68

5.40

2.0

1.8

—

Myeloproliferative diseases (CML excluded)

5.19

5.38

1.4

1.8

—

Other infectious diseases

5.19

5.38

1.5

2.5

—

Other diseases of oesophagus

5.19

5.38

3.2

1.5

—

Osteoporosis with pathological fracture (FG)

6.21

5.38

2.3

1.4

—

Disorders resulting from impaired renal tubular function

7.91

5.35

2.2

2.4

—

Nocardiosis

+∞

5.33

2.4

0.0

—

Glomerulonephritis

3.55

5.32

1.2

2.1

—

Rheumatoid arthritis, including avohilmo

193

2.18

5.32

1.2

1.9

—

Seropositive rheumatoid arthritis, strict definition

3.18

5.31

1.2

2.1

—

Sequelae with surgical and medical care as external cause

2.78

5.29

2.0

—

Other diseases of pericardium

6.70

5.25

2.2

1.8

—

Other leukaemias of specified cell type

+∞

5.25

1.6

0.0

—

Respiratory tuberculosis

6.69

5.25

2.2

1.7

—

Respiratory tuberculosis, confirmed and not-confirmed

6.69

5.25

2.2

1.7

—

Symptoms and signs involving the urinary system

369

1.74

5.25

2.2

2.0

—

Disorders of mineral metabolism

5.02

5.24

2.0

1.5

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.23

5.16

2.3

1.9

—

Gout, FINNGEN

132

2.42

5.15

2.3

—

Other disorders of pigmentation

7.37

5.14

3.6

1.3

—

Other degenerative diseases of the nervous system

2.61

5.11

2.0

1.7

—

Personal history of other diseases and conditions

4.83

5.09

3.6

1.0

—

Other benign neoplasms of skin

197

2.13

5.07

2.2

1.9

—

Lung cancer and mesothelioma

4.95

5.07

2.3

1.0

—

Glaucoma secondary to other eye disorders

8.38

5.06

1.0

2.5

—

Asthma, including avohilmo

125

447

1.57

5.05

2.7

1.8

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

10.04

5.02

1.6

2.6

—

Keratitis

185

2.16

5.00

1.9

2.0

—

Persons encountering health services for examination and investigation

157

1.95

4.99

2.2

1.5

—

Other coagulation defects

4.70

4.98

2.1

1.7

—

Other and unspecified disorders of white blood cells

6.91

4.95

2.5

2.3

—

Acute pharyngitis

3.38

4.95

1.0

1.4

—

Other disorders of urethra and urinary system

291

1.79

4.94

2.1

1.9

—

Acute generalized exanthematous pustulosis

6.03

4.91

2.7

1.6

—

Parasetamol

207

1.81

4.91

2.3

1.6

—

Misadventures to patients during surgical and medical care

3.12

4.90

1.3

2.0

—

Benign neoplasm: Colon

302

1.87

4.89

2.4

2.0

—

Cellulitis

106

2.55

4.86

2.1

1.7

—

Follow-up examination after treatment for conditions other than malignant neoplasms

124

2.19

4.85

2.2

1.5

—

Congenital malformations of the circulatory system

2.85

4.85

3.0

1.9

—

Persons with potential health hazards related to communicable diseases

199

2.09

4.84

2.2

1.9

—

Later onset COPD, excluding more controls

5.15

4.83

1.8

1.1

—

Phlebitis and thrombophlebitis (not including DVT)

107

2.53

4.78

2.2

1.9

—

Generalized skin eruption due to drugs and medicaments

6.51

4.77

2.8

1.8

—

Finngen Rheumatological endpoints

104

366

1.62

4.76

1.8

2.1

—

Use of antiglaucoma preparations and miotics

5.22

4.76

1.6

1.8

—

Other embolism and thrombosis

3.16

4.75

1.9

2.1

—

Abnormal results of function studies

4.43

4.74

3.1

2.3

—

conjunctival haemorrhage

4.68

4.67

2.0

1.8

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.02

4.66

1.7

—

Pericarditis

7.18

4.65

2.6

1.9

—

Benign neoplasm of colon, rectum, anus and anal canal

335

1.76

4.64

2.3

2.0

—

Angina pectoris

182

1.94

4.63

2.7

1.3

—

Genitourinary diseases

176

1.85

4.63

2.3

2.1

—

Other CVD (FINNGEN)

4.48

4.60

3.3

1.1

—

Other and unspecified coagulation defects

6.14

4.60

2.1

1.4

—

Other symptoms and signs involving the circulatory and respiratory systems

5.47

4.59

2.6

1.5

—

Malignant immunoproliferative diseases

14.24

4.59

1.6

—

Chronic myeloproliferative disease

14.18

4.59

1.1

1.6

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

122

2.38

4.54

1.1

2.0

—

Respiratory tuberculosis, confirmed

10.09

4.53

1.4

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

10.09

4.52

1.4

—

Other and unspecified diseases of blood and blood-forming organs

10.07

4.52

1.0

2.3

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

10.04

4.52

1.8

2.8

—

Mood disorders, excluding more controls

363

1.61

4.51

2.1

2.0

—

Mixed connective tissue disease

5.24

4.45

2.6

1.4

—

Deforming dorsopathies

162

2.16

4.41

2.2

1.8

—

Atrial fibrillation and flutter with reimbursement

2.65

4.39

2.6

1.3

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

2.33

4.36

1.1

2.1

—

Malignant neoplasm of breast, including Hilmo

2.33

4.36

1.1

2.1

—

Other and unspecified vascular occlusions

4.65

4.36

1.8

1.9

—

Fentanyl

4.64

4.35

1.6

1.9

—

Conjunctivitis (acute, non atopic)

143

2.23

4.35

1.8

1.9

—

Diseases of the digestive system

250

1.91

4.35

1.8

2.0

—

Other/unspecified seropositive rheumatoid arthritis

125

2.32

4.32

1.1

2.0

—

L01XX Other antineoplastic agents

5.02

4.31

1.0

1.9

—

Other demyelinating diseases of the central nervous system

6.28

4.29

2.2

1.4

—

Neovascular glaucoma

6.28

4.29

1.0

2.2

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

11.87

4.29

1.0

1.5

—

Diseases of tongue

6.27

4.29

1.4

1.6

—

Other epidermal thickening

5.53

4.29

2.6

1.8

—

Human immunodeficiency virus [HIV] disease

8.97

4.29

1.1

3.9

—

Osteonecrosis due to drugs

11.81

4.28

1.7

1.3

—

Seropositive rheumatoid arthritis

125

2.31

4.28

1.1

1.9

—

Other and unspecified tonsillitis

142

2.13

4.26

1.6

1.8

—

Malignant neoplasm of breast

2.33

4.23

1.1

2.2

—

Seropositive rheumatoid arthritis, wide

127

2.29

4.18

1.1

2.0

—

Other diseases of blood and blood-forming organs

4.82

4.18

1.8

2.5

—

Hypokalaemia

3.42

4.18

1.3

1.5

—

Volume depletion

4.81

4.18

2.4

1.6

—

Delirium, not induced by alcohol and other psychoactive substances

3.41

4.16

1.6

2.2

—

Sequelae of other external causes

5.26

4.14

1.6

2.0

—

Other specified/unspecified systemic involvement of connective tissue

5.26

4.14

2.7

1.3

—

Other arrhythmias

272

1.75

4.12

2.2

1.9

—

AV-block

2.92

4.08

2.1

1.5

—

Paralytic ileus and intestinal obstruction

122

2.30

4.08

2.2

1.8

—

Endocrine, nutritional and metabolic diseases

243

1.67

4.08

2.4

1.7

—

5-aminosalicylic acid

3.08

4.07

1.9

1.2

—

Other superficial mycoses

8.06

4.06

4.4

2.6

—

Carcinoma in situ of skin of upper limb, including shoulder

8.06

4.06

1.5

—

Other disorders of optic [2nd] nerve and visual pathways

4.63

4.05

2.6

1.8

—

Other complications of surgical and medical care, not elsewhere classified

3.34

4.04

2.6

2.2

—

Diverticular disease of intestine

273

1.68

4.02

2.3

2.1

—

Malignant neoplasm of mesothelium and soft tissue

10.04

4.01

1.1

1.7

—

Other peripheral vascular diseases

4.21

4.01

1.9

1.6

—

Acute tubulo-interstitial nephritis

278

1.77

3.99

2.0

1.8

—

Hyperkalaemia

5.57

3.97

2.8

1.3

—

Unspecified privation

3.03

3.96

2.2

2.0

—

GI-bleeding

150

2.14

3.94

1.6

1.9

—

Disorders of muscles

3.13

3.92

1.9

—

Pacemaker

125

2.23

3.92

2.1

1.8

—

Visual field defects

4.07

3.89

1.4

2.2

—

Ulcerative colitis, NAS

2.64

3.89

2.1

1.9

—

Benign neoplasm: Stomach

3.79

3.89

2.2

1.6

—

Hypothyroidism, drug reimbursement

4.71

3.88

2.1

1.5

—

Other or unspecified ileus, impaction or obstruction

2.63

3.88

2.7

1.8

—

Hypertensive diseases

290

1.62

3.87

2.4

2.0

—

Cerebral cysts

4.80

3.87

1.9

2.5

—

Other specified/unspecified bacterial intestinal infections

4.80

3.87

1.7

1.8

—

Injuries to the thorax

270

1.82

3.83

2.2

2.1

—

Fracture of rib(s), sternum and thoracic spine

152

2.11

3.82

2.2

2.0

—

Dialysis

6.03

3.81

1.1

2.2

—

Hyperlipidaemia, other/unspecified

183

1.96

3.81

2.2

1.9

—

Weight loss

3.69

3.79

2.4

2.0

—

Benign neoplasm: Ascending colon

2.84

3.78

2.2

1.9

—

Other melanin hyperpigmentation

8.81

3.78

3.4

1.4

—

Mood [affective] disorders

105

451

1.51

3.77

2.1

2.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

160

2.06

3.74

2.2

1.7

—

Mood disorders

105

451

1.51

3.74

2.1

2.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

3.60

3.69

1.9

2.3

—

Basal cell carcinoma

127

2.02

3.69

2.1

2.4

—

Blepharochalasis

128

2.19

3.69

2.2

1.8

—

Melanocytic naevi of trunk

2.79

3.68

3.3

1.8

—

Other and unspecified epidermal thickening

6.71

3.67

3.3

2.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

6.69

3.67

2.4

1.0

—

Hypertension

290

1.60

3.66

2.4

2.0

—

Hepatic failure, not elsewhere classified

5.65

3.66

1.6

2.1

—

Other diseases of urinary system

103

384

1.51

3.60

2.2

2.1

—

Hypothyroidism (congenital or acquired)

2.91

3.60

1.3

—

Ptosis of eyelid

3.72

3.58

1.8

1.4

—

Chronic pancreatitis

2.75

3.58

3.8

1.7

—

Malignant neoplasm of breast, HER2-negative

2.21

3.57

1.0

2.2

—

Noninfective enteritis and colitis

269

1.78

3.57

2.2

2.0

—

Cerebral palsy and other paralytic syndromes

2.95

3.57

1.5

2.0

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

7.85

3.56

1.1

3.9

—

Other and unspecified injuries of shoulder and upper arm

7.81

3.56

4.1

1.3

—

Urticaria and erythema

198

1.92

3.55

2.8

1.7

—

Cardiomyopathy

2.65

3.55

1.3

1.8

—

Disorders of vitreous body and globe

295

1.73

3.52

2.0

—

Basal cell carcinoma, including avohilmo

129

1.98

3.51

2.1

2.4

—

Melanocytic naevi of lower limb, including hip

5.32

3.51

3.2

1.6

—

Personal history of malignant neoplasm

5.31

3.51

1.3

1.0

—

Chronic apical periodontitis

111

429

1.47

3.50

1.9

2.0

—

Rheumatoid arthritis

184

1.90

3.49

1.2

2.0

—

Intestinal stricture

158

2.03

3.48

2.3

2.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

262

1.78

3.47

1.9

2.0

—

Type 1 diabetes

125

2.16

3.45

1.6

1.9

—

Other arthritis (FG)

166

1.99

3.42

1.4

2.0

—

Pain in joint

208

1.72

3.40

1.9

1.8

—

L04AC Interleukin inhibitors

4.09

3.39

1.2

2.6

—

Paralytic strabismus

4.09

3.39

1.5

1.9

—

Congenital malformations of cardiac septa

4.11

3.39

2.2

2.1

—

Other diseases of the digestive system

153

2.03

3.39

1.6

1.9

—

Episodal and paroxysmal disorders

106

364

1.48

3.37

2.4

1.9

—

Superficial injury of head

107

2.24

3.37

1.2

1.9

—

Follicular lymphoma, hilmo

5.02

3.37

1.1

2.2

—

Myocardial infarction

159

1.86

3.37

2.2

1.3

—

Other disorders of kidney and ureter

2.84

3.35

1.9

—

Other disorders of bone

2.36

3.31

1.9

2.0

—

Other congenital malformations

3.43

3.30

2.2

2.1

—

Abnormal weight loss

3.64

3.28

2.6

1.7

—

Etanercept

3.94

3.28

1.5

2.3

—

Diabetic nephropathy

2.41

3.28

1.8

2.4

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

441

1.48

3.27

2.1

2.0

—

Disorders of thyroid, IBD co-morbidities

2.93

3.26

2.8

1.2

—

Polyuria

109

2.20

3.24

2.4

2.0

—

Peripheral artery operations in Hilmo

3.03

3.24

1.1

1.8

—

Varicella [chickenpox]

4.75

3.23

3.0

2.3

—

Nasal polyp

2.38

3.22

2.7

1.7

—

Diabetic nephropathy, excluding more controls

2.42

3.20

1.8

2.7

—

Glucagon-like peptide-1 (GLP-1) analogues

202

0.30

3.19

3.5

2.2

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

202

0.30

3.19

3.5

2.2

—

Papilloedema, unspecified

6.40

3.19

3.1

1.6

—

Other diseases of spinal cord

6.39

3.18

1.3

2.5

—

Family history of certain disabilities and chronic diseases leading to disablement

6.38

3.18

1.0

—

Myocarditis

6.38

3.18

1.6

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

411

1.48

3.17

1.9

2.1

—

Nail disorders

3.26

3.13

3.8

2.2

—

Hypothyroidism and >3 levothyroxin purchases

2.75

3.12

1.2

1.3

—

Hypothyroidism, levothyroxine purchases

2.75

3.12

1.2

1.3

—

Other disorders of eye and adnexa

2.54

3.12

1.4

1.8

—

Other CVD

2.47

3.12

2.9

1.8

—

Stroke, excluding SAH

269

1.63

3.11

1.6

2.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

4.51

3.11

3.3

2.0

—

External causes of morbidity and mortality

208

1.61

3.11

2.1

2.0

—

Disorders of gallbladder, biliary tract and pancreas

422

1.46

3.10

2.3

2.0

—

Diseases of oral cavity, salivary glands and jaws

155

1.73

3.10

2.0

1.8

—

Osteomyelitis

4.01

3.08

2.4

2.0

—

Hydrocephalus

4.01

3.08

1.2

1.8

—

Ascites

4.01

3.08

1.3

1.6

—

Acute gastritis

4.01

3.08

2.6

1.6

—

Systemic sclerosis

7.54

3.06

3.3

1.4

—

Low back pain

357

1.53

3.03

2.1

2.0

—

Diabetic retinopathy, excluding more controls

2.05

3.03

1.8

2.5

—

Malignant neoplasm of breast, HER-negative

2.90

3.02

1.0

1.9

—

Hodgkin lymphoma, hilmo

5.86

3.02

1.4

2.0

—

Erythema nodosum

5.86

3.02

2.4

1.8

—

Carcinoma in situ of skin of trunk

5.86

3.02

1.9

1.5

—

Endocarditis

5.86

3.02

1.0

2.1

—

Abnormal findings on diagnostic imaging of other body structures

2.89

3.02

1.1

1.8

—

Disorders of conjunctiva

427

1.50

3.02

2.0

—

Disorders of vitreous body

289

1.67

3.01

1.8

2.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

138

2.01

3.00

1.4

1.9

—

Other and unspecified iridocyclitis

4.30

2.99

1.1

2.7

—

Hordeolum and other deep inflammation of eyelid

4.30

2.99

2.1

1.7

—

Dermatopolymyositis (FG)

10.08

2.98

3.8

1.4

—

Other and unspecified glaucoma

3.85

2.98

1.2

1.8

—

Diabetes, varying definitions

100

405

1.45

2.97

2.2

1.9

—

Hypotension

2.63

2.96

3.3

2.0

—

Corneal ulcer

2.24

2.95

2.1

1.9

—

Polycystic ovarian syndrome, consortium definition

224

1.61

2.95

2.0

1.7

—

Ischaemic Stroke, excluding all haemorrhages

250

1.64

2.95

1.5

2.1

—

Diseases of middle ear and mastoid

276

1.63

2.94

2.0

1.9

—

Inflammatory bowel disease

176

1.88

2.94

2.2

1.9

—

Raynaud syndrome

3.25

2.93

1.8

1.5

—

Tumor necrosis factor alpha inhibitors

2.28

2.93

1.4

2.1

—

Varicella [chickenpox]

4.72

2.92

2.8

2.5

—

Type 2 diabetes, wide definition

346

1.50

2.90

2.0

2.1

—

Diseases of the ear and mastoid process

115

409

1.41

2.90

2.1

2.0

—

Other osteochondropathies

3.45

2.89

1.4

2.5

—

Aortic aneurysm

2.22

2.89

2.4

2.1

—

Disorders of lipoprotein metabolism and other lipidaemias

295

1.53

2.88

2.3

2.0

—

Tongue abnormality

4.10

2.88

1.4

2.0

—

Melanocytic naevi of other and unspecified parts of face

4.10

2.88

1.1

2.0

—

Depression

440

1.45

2.87

2.1

—

Chronic conjunctivitis

5.41

2.87

1.6

2.3

—

Systemic sclerosis, icd10

6.70

2.87

3.3

1.8

—

Viral agents as the cause of diseases classified to other chapters

6.70

2.87

2.5

1.4

—

Viral conjunctivitis

5.40

2.87

1.1

1.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

350

1.60

2.86

1.7

2.1

—

Ulcerative colitis

122

2.05

2.86

2.2

2.0

—

Other and unspecified drugs and medicaments

3.17

2.84

1.8

2.0

—

Amputation

3.16

2.84

1.1

1.9

—

Other functional intestinal disorders

219

1.74

2.83

1.5

1.6

—

Optic neuritis

4.46

2.79

1.0

1.4

—

Oesophagitis

4.46

2.79

1.6

1.7

—

Combinations of oral blood glucose lowering drugs

189

0.32

2.79

1.3

2.2

—

Urethral stricture

3.92

2.77

2.9

2.0

—

Other systemic involvement of connective tissue (FG)

122

2.02

2.76

1.9

1.8

—

Malignant neoplasm of testis, including Hilmo

8.38

2.75

1.0

3.0

—

Viral conjunctivitis

8.37

2.75

1.2

1.5

—

Other systemic involvement of connective tissue

124

2.02

2.75

1.9

—

Irregular menses

193

1.72

2.74

2.0

1.7

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

5.02

2.73

2.0

2.4

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.86

2.73

2.2

2.0

—

Duodenal ulcer

3.24

2.72

1.3

1.6

—

Any mental disorder

104

367

1.42

2.72

2.2

2.0

—

Malignant neoplasm of breast, ER-negative, including Hilmo

2.62

2.71

1.0

2.1

—

Hypertension, essential

282

1.51

2.71

2.2

2.0

—

Benign neoplasm: Duodenum

6.03

2.70

2.0

1.6

—

Disorders of skin appendages

286

1.64

2.69

2.9

1.9

—

Malignant melanoma

3.00

2.69

2.3

2.1

—

Other diseases of anus and rectum

146

1.92

2.67

1.9

1.8

—

Lichen simplex chronicus and prurigo

3.76

2.67

1.8

1.7

—

Gout

153

1.84

2.66

2.3

—

Other symptoms and signs involving cognitive functions and awareness

233

1.68

2.66

1.7

1.8

—

Unspecified haematuria

199

1.71

2.65

2.3

2.1

—

Seborrhoeic dermatitis

2.80

2.64

2.9

2.0

—

Disturbances of skin sensation

140

1.93

2.64

2.6

1.9

—

Fall on same level

112

441

1.39

2.63

1.9

2.1

—

Dental operations

167

1.63

2.63

1.7

1.8

—

Major coronary heart disease event excluding revascularizations

194

1.65

2.62

2.3

1.3

—

Other mental disorders due to brain damage and dysfunction and to physical disease

2.93

2.61

1.3

2.1

—

Septal defects

3.68

2.61

2.4

2.2

—

Ocular pain

3.34

2.60

1.2

1.6

—

Hypoparathyroidism

4.68

2.60

2.1

1.5

—

Vulvovaginal ulceration/inflammation in other diseases

3.61

2.57

2.4

1.8

—

Visual impairment including blindness (binocular or monocular)

3.61

2.57

1.2

2.0

—

Disorders of refraction and accommodation

141

1.91

2.56

2.0

1.8

—

Stroke, including SAH

288

1.54

2.55

1.6

2.1

—

Dermatopolymyositis

7.20

2.55

3.8

1.4

—

Background retinopathy and retinal vascular changes

7.18

2.55

1.6

—

Primary biliary cholangitis (PBC)

7.18

2.55

1.0

1.7

—

Chronic Coagulation defects

7.17

2.55

1.6

1.9

—

Glaucoma

269

1.60

2.55

1.5

1.9

—

Systemic sclerosis (FG)

5.48

2.54

3.3

1.4

—

Myositis

5.48

2.54

1.2

1.3

—

Disorders of tooth development and eruption

2.40

2.54

1.6

1.8

—

Complications of procedures, not elsewhere classified

404

1.47

2.54

1.5

2.0

—

Malignant neoplasm of stomach, including Hilmo

5.46

2.54

1.8

2.3

—

Spondylolisthesis/Spondylolysis

2.13

2.54

2.5

2.0

—

Other congenital malformations

2.42

2.53

2.8

1.9

—

Cervicocranial syndrome

2.60

2.53

2.2

—

Diabetes mellitus

409

1.40

2.49

2.2

2.0

—

Other noninfective gastroenteritis and colitis

115

2.00

2.49

2.3

2.0

—

Symptoms and signs involving speech and voice

172

1.80

2.49

1.5

1.9

—

Amenorrhoea

3.47

2.48

1.7

2.0

—

Benign neoplasm: Small intestine

4.39

2.47

1.9

2.2

—

Herpesviral keratitis and keratoconjunctivitis

4.39

2.47

2.1

2.2

—

Localized swelling, mass and lump of skin and subcutaneous tissue

158

1.84

2.47

2.0

1.9

—

Other diseases of stomach and duodenum

3.82

2.46

2.9

1.7

—

Malignant neoplasm of head and neck

3.81

2.46

1.4

2.6

—

Pain (limb, back, neck, head abdominally)

210

1.53

2.44

1.9

1.8

—

Other retinal disorders

289

1.54

2.43

1.6

2.2

—

Sub-endpoint used in defining T1D endpoints

135

1.90

2.43

1.6

1.9

—

Conduction disorders

116

1.89

2.41

1.8

—

Allergic urticaria

2.90

2.41

2.3

1.6

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

2.90

2.41

2.0

—

Amputation of foot

5.02

2.40

1.0

2.2

—

Diseases of salivary glands

167

1.80

2.39

2.3

1.9

—

Corns and callosities

3.34

2.39

1.1

1.9

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

3.34

2.39

2.8

2.3

—

Obstructive hydrocephalus

6.29

2.37

1.2

1.4

—

Other specified/unspecified deforming dorsopathies

6.28

2.37

2.0

2.9

—

Other and unspecified nail disorders

6.28

2.37

4.8

1.6

—

Viral agents as the cause of diseases classified to other chapters

6.28

2.37

2.8

1.5

—

Prurigo nodularis

6.28

2.37

2.4

2.0

—

Insomnia

460

0.62

2.36

1.8

2.0

—

Unstable angina pectoris

125

1.83

2.36

2.4

1.3

—

Intestinal malabsorption

4.13

2.36

1.7

1.9

—

Juvenile arthritis (FINNGEN)

4.13

2.36

1.0

1.8

—

Other endocrine disorders

3.66

2.35

1.9

1.7

—

Benign neoplasm: Transverse colon

2.61

2.35

3.1

1.9

—

Retinal detachment with retinal break

2.50

2.35

1.9

2.0

—

Nonischemic cardiomyopathy

2.82

2.33

1.8

1.9

—

Acute nasopharyngitis (common cold)

2.49

2.32

1.9

2.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

2.08

2.32

1.1

2.1

—

Exclusions for E4_PCOS_BROAD

2.09

2.32

1.7

2.0

—

Impotence

3.22

2.30

4.0

2.4

—

Amputation of toe

3.22

2.30

1.1

1.8

—

Peripheral artery disease

181

1.67

2.29

1.7

2.0

—

Open wound of ankle and foot

2.38

2.29

1.7

2.0

—

Other (seronegative) rheumatoid arthritis, wide

2.12

2.28

1.3

2.1

—

Caries of enamel

444

1.40

2.27

2.0

—

Congenital malformations, deformations and chromosomal abnormalities

354

1.51

2.27

2.4

2.0

—

Other specified and unspecified disorders of eye and adnexa

4.63

2.27

1.3

2.4

—

Simple and mucopurulent chronic bronchitis

4.63

2.27

2.3

1.6

—

Oesophageal varices

3.49

2.27

1.8

2.3

—

Need for other prophylactic measures

3.49

2.27

1.0

2.5

—

Aortic valve malfunction, age under 60 years

2.56

2.27

2.5

2.3

—

Acetic acid derivatives and related substances

137

0.42

2.26

1.1

2.3

—

Lower back pain or/and sciatica

468

1.37

2.25

2.2

2.0

—

Congenital malformations of heart and great arteries

2.27

2.22

2.7

2.1

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

3.11

2.22

2.0

1.7

—

Malnutrition

5.58

2.21

1.4

1.3

—

Erythema multiforme

5.58

2.21

5.2

1.8

—

5.58

2.21

1.2

2.7

—

Disorders of parathyroid gland

2.09

2.21

1.6

1.9

—

Collagenous colitis

2.86

2.20

2.5

1.6

—

Suggestive for eosinophilic asthma

2.69

2.20

1.8

1.9

—

Distal bite

5.53

2.20

2.6

1.2

—

Chronic periodontitis, complicated

364

1.50

2.19

2.7

2.0

—

Malignant melanoma, including Hilmo

2.41

2.19

2.2

2.1

—

Inguinal hernia, bilateral

2.50

2.18

2.5

2.3

—

Valvular operations

2.50

2.18

1.3

1.9

—

Ingrowing nail

3.34

2.18

3.7

2.5

—

Decubitus ulcer and pressure area

3.34

2.18

1.9

1.8

—

Diseases of male genital organs

181

1.53

2.17

2.4

2.3

—

Dorsalgia

366

1.38

2.17

2.4

2.0

—

Manic episode

4.30

2.15

2.8

2.2

—

Respiratory tuberculosis, not confirmed

4.30

2.15

3.0

1.7

—

Somnolence, stupor and coma

4.30

2.15

1.5

2.4

—

Migraine

239

1.56

2.15

1.8

—

Other abnormal findings of blood chemistry

3.69

2.15

4.1

2.0

—

Other aneurysm

3.69

2.15

3.1

1.8

—

Rash and other nonspecific skin eruption

2.62

2.14

2.9

1.7

—

Exposure to unspecified factor

485

1.36

2.13

1.9

2.0

—

Deviated nasal septum

196

1.68

2.13

2.1

2.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

166

1.67

2.12

1.7

2.0

—

Irritable bowel syndrome

137

1.83

2.12

1.7

—

Diabetic retinopathy

120

1.72

2.11

1.8

2.3

—

Other superficial mycoses

2.45

2.10

3.4

1.6

—

Inguinal or femoral hernia, bilateral

2.45

2.10

2.5

2.3

—

Acute peritonitis

3.21

2.09

1.5

2.1

—

Spondylopathies

317

1.41

2.08

2.1

2.0

—

Unspecified nephritic syndrome

5.02

2.07

1.0

1.3

—

Anaemia in chronic diseases classified elsewhere

5.02

2.07

1.2

1.9

—

Thoracic aortic aneurysm

2.26

2.07

2.9

2.2

—

Other diseases of hard tissues of teeth

155

1.57

2.07

1.7

1.8

—

Sequelae of infectious and parasitic diseases

2.91

2.07

1.4

2.5

—

Malignant neoplasm of stomach

5.01

2.07

2.0

1.5

—

2.27

2.07

1.3

1.5

—

Follow-up examination after treatment for malignant neoplasms

2.91

2.07

1.1

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.03

2.06

2.4

1.8

—

Appendectomy

438

0.59

2.06

2.2

2.0

—

Abnormal findings on examination of urine, without diagnosis

3.51

2.05

2.7

1.9

—

Lesion of lateral popliteal nerve

3.51

2.05

3.4

2.3

—

Hyperfunction of pituitary gland

3.51

2.05

1.6

1.7

—

Unknown and unspecified causes of morbidity

3.51

2.05

1.7

2.3

—

Sixth [abducent] nerve palsy

4.01

2.04

1.8

2.0

—

Other specified and unspecified retinal disorders

4.01

2.04

2.0

2.3

—

Other disorders of prostate

4.01

2.04

1.5

2.1

—

Vascular syndromes of brain in cerebrovascular disorders

4.01

2.04

1.2

2.3

—

Other diseases of lip and oral mucosa

230

1.61

2.04

1.9

—

Sleep disorders

465

0.65

2.04

1.7

2.0

—

Atrial septal defect

3.98

2.02

2.2

2.3

—

Sleep apnoea

412

1.37

2.02

2.4

1.9

—

Type 2 diabetes

391

1.36

2.01

1.9

2.0

—

Other/unspecified reactive arthropathies

3.08

2.01

2.9

1.7

—

Other and unspecified visual disturbances

2.50

2.01

1.3

2.0

—

Diseases of peritoneum

2.50

2.01

1.5

2.0

—

Disorders of speech understanding and production

3.93

2.00

1.3

1.5

—

Impacted cerumen

2.64

2.00

1.2

1.9

—

Special screening examination for other diseases and disorders

2.63

2.00

2.3

1.2

—

Other problems related to primary support group, including family circumstances

2.39

1.98

1.0

2.2

—

Primary gonarthrosis, bilateral

290

0.53

1.97

1.4

2.1

—

Bell's palsy

2.28

1.97

1.7

2.1

—

Coxibs

138

0.46

1.97

1.2

2.3

—

Myocardial infarction, unclassifiable

2.16

1.97

1.7

1.9

—

Vascular disorders of the intestines

3.34

1.96

1.3

1.6

—

Inguinal hernia

244

1.48

1.95

2.4

2.2

—

Chondropathies

2.03

1.95

2.0

1.9

—

Other shoulder lesions

2.36

1.94

2.7

1.9

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.36

1.94

2.5

2.2

—

Diseases of liver

202

1.63

1.94

2.0

—

Other misadventures during surgical and medical care

4.56

1.94

1.6

—

IgA nephropathy (IgA glomerulonephritis)

4.56

1.94

1.2

2.3

—

Haemorrhage, not elsewhere classified

4.56

1.94

1.6

2.5

—

Amiodarone users

2.57

1.94

2.0

1.9

—

Intracerebral haemorrhage

2.57

1.94

2.2

1.8

—

Other specified/unspecified arthritis

164

1.71

1.93

1.5

2.0

—

Other and unspecified follicular disorders

3.76

1.93

1.3

2.9

—

Other congenital malformations of skin

3.76

1.93

2.8

1.5

—

Complications of other internal prosthetic devices, implants and grafts

3.76

1.93

2.0

1.7

—

Other juvenile arthritis

3.76

1.93

1.0

1.9

—

Chronic ulcer of skin, not elsewhere classified

2.97

1.93

1.9

2.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

362

1.46

1.93

1.8

2.0

—

Degenerative macular diseases

2.73

1.93

2.1

1.8

—

Cardiomyopathies, Primary/intrinsic

2.45

1.92

1.5

1.8

—

Heart failure and bmi 25plus

119

1.70

1.92

2.3

2.1

—

Gout, idiopatic and unspecified

120

1.83

1.92

2.5

2.1

—

Vasomotor and allergic rhinitis

199

1.63

1.91

2.6

1.8

—

FESS (DNB20)

2.24

1.90

2.9

1.6

—

Superficial injury of hip and thigh

2.24

1.90

1.5

2.0

—

Hypoplasia of dental enamel , including avohilmo

4.42

1.89

2.4

1.2

—

Myocardial infarction, strict

154

1.62

1.89

2.1

1.3

—

Abnormalities of forces of labour

0.00

1.88

0.0

1.7

—

Molar incisor enamel hypoplasia

4.39

1.88

2.4

1.2

—

Malignant neoplasm of kidney, except renal pelvis

3.19

1.88

1.6

2.5

—

Congenital malformations, deformations and chromosomal abnormalities

389

1.42

1.87

2.5

1.9

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.65

1.86

1.2

2.1

—

Infectious mononucleosis

2.65

1.86

1.0

2.6

—

Cardiomyopathy, other and unspecified

2.86

1.86

1.3

2.1

—

Organic, including symptomatic, mental disorders

194

1.54

1.86

1.5

2.0

—

Other diseases of arteries and capillaries

2.86

1.86

2.0

1.7

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2.09

1.86

2.0

2.2

—

Diabetes medication

424

1.33

1.84

2.2

1.9

—

Benign neoplasm: Sigmoid colon

1.98

1.84

1.9

1.8

—

Ethmoidectomy

2.21

1.84

2.9

1.6

—

Scar conditions and fibrosis of skin

3.54

1.84

2.2

1.4

—

Insulin, intermediate and long-acting

324

1.47

1.83

1.8

2.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

237

1.56

1.83

1.9

—

1.87

1.82

1.6

1.5

—

Idiopathic thrombocytopenic purpura

4.18

1.82

1.0

1.5

—

Malignant neoplasm of oral cavity, including Hilmo

4.17

1.82

1.2

2.2

—

Acute laryngitis and tracheitis

2.61

1.82

1.7

1.6

—

Disease of hard tissues of teeth, NOS

154

1.53

1.82

2.1

1.9

—

Other and unspecified disorders of vitreous body

234

1.56

1.82

1.9

2.0

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2.12

1.81

2.1

2.0

—

Pure hypercholesterolaemia

275

1.42

1.80

2.1

2.0

—

Migraine without aura

101

1.88

1.80

2.6

1.7

—

Erectile dysfunction

2.58

1.80

1.0

2.0

—

Nummular dermatitis

2.58

1.80

2.9

1.8

—

Benign neoplasm: Choroid

3.05

1.80

1.9

—

Speech and linguistic disorders, excluding more controls

2.79

1.80

2.3

1.6

—

Migraine without aura and triptan purchases

2.00

1.79

2.8

2.0

—

Dermatophytosis

368

1.44

1.79

1.9

2.0

—

Malignant melanoma of skin

2.76

1.79

2.0

—

Nerve, nerve root and plexus disorders

446

1.32

1.79

1.9

2.0

—

Non-small cell lung cancer, including Hilmo

2.36

1.77

2.6

2.3

—

Diabetic maculopathy, excluding more controls

2.34

1.77

1.7

1.5

—

Other keratitis

2.17

1.77

1.1

2.0

—

Other anxiety disorders

214

1.54

1.74

2.6

1.9

—

Fibrosis and cirrhosis of liver

2.50

1.74

2.1

1.7

—

Hypopituitarism

2.50

1.73

2.3

—

Exclusions for E4_PCOS_CONSORTIUM

266

1.41

1.72

1.8

1.9

—

Other specified/unspecified hearing loss

2.67

1.72

1.6

2.0

—

Pleural plaque

2.67

1.72

2.9

1.6

—

Suppurative and necrotic conditions of lower respiratory tract

2.92

1.72

1.9

2.5

—

Acute lymphadenitis

2.92

1.72

1.6

2.4

—

Malignant neoplasm of bladder, including Hilmo

2.49

1.72

3.2

2.5

—

Malignant neoplasm of urinary organs

2.92

1.72

1.6

2.4

—

Entropion and trichiasis of eyelid

2.92

1.72

2.0

1.3

—

Recurrent or chronic depression

190

1.52

1.71

2.8

2.0

—

Certain zoonotic bacterial diseases

3.86

1.71

2.8

1.8

—

Nephrotic syndrome

3.86

1.71

1.0

1.5

—

Muscle strain

3.86

1.71

2.8

1.2

—

Adrenocortical insufficiency

3.86

1.71

1.2

1.5

—

Convalescence

3.85

1.71

2.8

1.8

—

Noninfectious colitis NAS

2.13

1.71

2.3

1.8

—

Fitting and adjustment of other devices

119

1.75

1.71

2.2

1.6

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

235

0.52

1.71

1.9

1.8

—

Cardiomyopathy (excluding other)

2.29

1.70

1.5

2.1

—

Poor fetal growth

2.29

1.70

2.0

1.5

—

Malignant neoplasm of breast, HER-positive

1.90

1.68

1.1

2.1

—

Fracture of lumbar spine and pelvis

1.95

1.68

1.1

1.7

—

Reactive arthropathies, FINNGEN

2.58

1.66

2.9

2.3

—

Calcific aortic valvular stenosis, operated

108

1.80

1.65

1.4

1.9

—

Calcific aortic valvular stenosis

108

1.80

1.65

1.4

1.9

—

Operations 2 for CAVS

108

1.80

1.65

1.4

1.9

—

Calcific aortic valvular stenosis, diagnosis (helper)

108

1.80

1.65

1.4

1.9

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

292

1.43

1.65

2.2

2.0

—

Calcific aortic valvular stenosis, including rheumatic fever

108

1.79

1.65

1.4

1.9

—

Other and unspecified disorders of skin and subcutaneous tissue

2.80

1.65

3.0

1.7

—

Other disorders of nervous system

2.80

1.65

2.3

1.9

—

Other noninflammatory disorders of vagina

2.80

1.65

1.0

2.0

—

Sequelae of cerebrovascular disease

148

1.63

1.64

1.9

—

Persons encountering health services in circumstances related to reproduction

256

1.42

1.64

2.1

2.0

—

Retinal breaks without detachment

1.98

1.64

1.2

2.1

—

Tinnitus

135

1.71

1.62

1.7

2.0

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.58

1.61

1.0

1.3

—

Temporal arteritis

3.58

1.61

1.2

1.6

—

Arthropathies in other diseases classified elsewhere

3.58

1.61

2.0

—

Subjective visual disturbances

120

1.75

1.61

2.1

2.0

—

Chronic tubulo-interstitial nephritis

3.58

1.61

1.0

1.8

—

Pruritus

2.38

1.61

2.8

1.6

—

Gout, unspecified

1.84

1.61

2.6

2.2

—

Injury of muscle and tendon at lower leg level

1.95

1.59

1.7

2.0

—

Perforation of tympanic membrane

2.33

1.58

2.0

—

Neuralgia and neuritis, unspecified

3.01

1.58

2.0

1.5

—

Cardiac arrest

3.56

1.58

2.4

1.2

—

Conjunctivitis

393

1.36

1.57

2.1

1.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.89

1.55

2.6

1.9

—

Other/unspecified rheumatoid arthritis

2.28

1.55

1.3

1.7

—

Superficial injury of abdomen, lower back and pelvis

1.92

1.54

1.3

1.9

—

Polypectomy (DHB20)

2.43

1.53

3.1

1.9

—

Other follicular disorders

2.43

1.53

1.3

2.3

—

Spinal stenosis

237

1.44

1.52

2.2

2.0

—

Giant cell arteritis with polymyalgia rheumatica

3.34

1.52

1.2

1.8

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS